The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Jazz Pharmaceuticals JAZZ reported third-quarter 2025 adjusted earnings per share (EPS) of $8.13 per share, beating the Zacks Consensus Estimate of $5.74. This beat was largely due to an income tax ...
Jazz Pharmaceuticals reported a 37.1% EPS surprise, beating market expectations. Revenue grew by 7% year-over-year, driven by strong product sales. Stock declined 0.44% in after-hours trading despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results